The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos
- PMID: 20223579
- DOI: 10.1016/j.ejogrb.2010.02.029
The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos
Abstract
Objective: To investigate whether anti-Müllerian hormone (AMH) is better than antral follicle count (AFC) in predicting oocyte yield and embryo quality after controlled ovarian hyperstimulation for in vitro fertilization (IVF).
Study design: This is a prospective observational study involving 162 women (<40 years old) undergoing their first IVF cycle at an IVF unit within a university hospital. AMH and AFC measurements were made on day 3 of the cycle within 3 months of starting ovarian stimulation. A standard long down-regulation protocol using gonadotrophin releasing hormone agonist and recombinant follicle stimulating hormone was used. A maximum of two embryos were transferred on day 2 or 3 following oocyte retrieval. The primary outcome was the number of good quality embryos available for transfer and freezing. Embryos were graded according to the number of blastomeres, the difference in blastomere size and the degree of fragmentation, into grades 1-4. Secondary outcomes included the number of oocytes retrieved and fertilized and the live birth rate. Correlation between different parameters was calculated using Spearman's correlation coefficient. Receiver operating characteristic (ROC) curves were generated for AMH and AFC to compare ability of parameters to predict top quality or frozen embryos and the occurrence of a live birth.
Results: Of the 137 women who had fresh embryo transfer, 52 became pregnant (32.1% pregnancy rate per cycle started) and 38 had a live birth (23.5% live birth rate per cycle started). Both AMH and AFC had highly significant correlations with the number of oocytes retrieved and the number of oocytes fertilized (P<0.001). The two markers were also significantly associated with the number of top quality embryos available for transfer and the number of embryos frozen (P<0.01). With regard to live birth, AMH performed better than AFC (P<0.01 and P<0.05, respectively), but both markers were more valuable in predicting the absence rather than the occurrence of live birth (negative predictive value 84%).
Conclusions: AMH and AFC are comparable predictors of oocytes retrieved and of the number of good quality embryos available for transfer and freezing. Prediction of live birth may help clinicians selecting patients suitable for single embryo transfer.
Copyright 2010 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.Fertil Steril. 2009 Nov;92(5):1586-93. doi: 10.1016/j.fertnstert.2008.08.127. Epub 2008 Oct 18. Fertil Steril. 2009. PMID: 18930213 Clinical Trial.
-
Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?Eur J Obstet Gynecol Reprod Biol. 2018 Feb;221:151-155. doi: 10.1016/j.ejogrb.2017.12.047. Epub 2017 Dec 29. Eur J Obstet Gynecol Reprod Biol. 2018. PMID: 29306180
-
Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.Fertil Steril. 2008 Jun;89(6):1670-6. doi: 10.1016/j.fertnstert.2007.05.040. Epub 2007 Jul 20. Fertil Steril. 2008. PMID: 17658520
-
Outcomes from ovarian hyperstimulation following the sole administration of gonadotrophin-releasing hormone agonist in the context of in vitro fertilization: report of two cases and review of the literature.Gynecol Endocrinol. 2012 Jul;28(7):545-8. doi: 10.3109/09513590.2011.650745. Epub 2012 Mar 23. Gynecol Endocrinol. 2012. PMID: 22439899 Review.
-
Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction.Reprod Biomed Online. 2014 Feb;28(2):183-90. doi: 10.1016/j.rbmo.2013.10.012. Epub 2013 Oct 25. Reprod Biomed Online. 2014. PMID: 24368127 Review.
Cited by
-
A comparative study on the results of agonist and antagonist protocols based on serum AMH levels in patients undergoing intracytoplasmic sperm injection.Int J Reprod Biomed. 2016 Dec;14(12):769-776. Int J Reprod Biomed. 2016. PMID: 28066836 Free PMC article.
-
Baseline AMH Level Associated With Ovulation Following Ovulation Induction in Women With Polycystic Ovary Syndrome.J Clin Endocrinol Metab. 2016 Sep;101(9):3288-96. doi: 10.1210/jc.2016-1340. Epub 2016 May 26. J Clin Endocrinol Metab. 2016. PMID: 27228369 Free PMC article. Clinical Trial.
-
Serum anti-Mullerian hormone levels correlate with ovarian response in idiopathic hypogonadotropic hypogonadism.J Assist Reprod Genet. 2012 Jul;29(7):597-602. doi: 10.1007/s10815-012-9759-1. Epub 2012 May 1. J Assist Reprod Genet. 2012. PMID: 22547042 Free PMC article.
-
Reproductive outcomes from ten years of elective oocyte cryopreservation.Arch Gynecol Obstet. 2022 Nov;306(5):1753-1760. doi: 10.1007/s00404-022-06711-0. Epub 2022 Aug 21. Arch Gynecol Obstet. 2022. PMID: 35988095 Free PMC article.
-
Anti-Müllerian hormone (AMH): a reliable biomarker of oocyte quality in IVF.J Assist Reprod Genet. 2014 Apr;31(4):493-8. doi: 10.1007/s10815-014-0193-4. Epub 2014 Feb 27. J Assist Reprod Genet. 2014. PMID: 24573377 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources